These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18757187)

  • 1. Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer.
    Teoh DC; Rodger S; Say J; Hartley A
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):717. PubMed ID: 18757187
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer.
    Chan A; Teoh D; Sanghera P; Hartley A
    Radiother Oncol; 2009 Dec; 93(3):654. PubMed ID: 19524312
    [No Abstract]   [Full Text] [Related]  

  • 3. Cetuximab plus radiotherapy for head and neck cancer.
    Armstrong JG
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710907
    [No Abstract]   [Full Text] [Related]  

  • 4. Cetuximab plus radiotherapy for head and neck cancer.
    Cengiz M; Yildiz F; Genc M
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710908
    [No Abstract]   [Full Text] [Related]  

  • 5. Cetuximab plus radiotherapy for head and neck cancer.
    Ho AC
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16707760
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines.
    Bernier J; Russi EG; Homey B; Merlano MC; Mesía R; Peyrade F; Budach W
    Ann Oncol; 2011 Oct; 22(10):2191-200. PubMed ID: 21606209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cetuximab and radiotherapy for head and neck cancer.
    Posner MR; Wirth LJ
    N Engl J Med; 2006 Feb; 354(6):634-6. PubMed ID: 16467552
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe cutaneous reaction during radiation therapy with concurrent cetuximab.
    Budach W; Bölke E; Homey B
    N Engl J Med; 2007 Aug; 357(5):514-5. PubMed ID: 17671265
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
    Bonner JA; Harari PM; Giralt J; Cohen RB; Jones CU; Sur RK; Raben D; Baselga J; Spencer SA; Zhu J; Youssoufian H; Rowinsky EK; Ang KK
    Lancet Oncol; 2010 Jan; 11(1):21-8. PubMed ID: 19897418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
    Bonner JA; Harari PM; Giralt J; Azarnia N; Shin DM; Cohen RB; Jones CU; Sur R; Raben D; Jassem J; Ove R; Kies MS; Baselga J; Youssoufian H; Amellal N; Rowinsky EK; Ang KK
    N Engl J Med; 2006 Feb; 354(6):567-78. PubMed ID: 16467544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetuximab plus radiotherapy for head and neck cancer.
    Hartig F; Pechlaner C
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710909
    [No Abstract]   [Full Text] [Related]  

  • 12. More on cetuximab in head and neck cancer.
    Mell LK; Weichselbaum RR
    N Engl J Med; 2007 Nov; 357(21):2201-2; author reply 2202-3. PubMed ID: 18032774
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute toxicity in 14 patients with locally advanced head and neck squamous cell carcinoma treated with concurrent cetuximab and radiotherapy.
    Valeriani M; Muni R; Osti MF; De Sanctis V; Minniti G; Ardito F; Maurizi Enrici R
    Radiol Med; 2012 Feb; 117(1):125-32. PubMed ID: 21892718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acneiform rash secondary to cetuximab plus head and neck radiotherapy.
    Mydin AR; Armstrong JG
    Radiother Oncol; 2007 Oct; 85(1):171. PubMed ID: 17531339
    [No Abstract]   [Full Text] [Related]  

  • 15. StatBite: Radiation therapy plus cetuximab: skin reactions from 71 head and neck cancer patients from 11 institutions in Europe.
    J Natl Cancer Inst; 2010 Jan; 102(2):75. PubMed ID: 20054017
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study.
    Merlano M; Russi E; Benasso M; Corvò R; Colantonio I; Vigna-Taglianti R; Vigo V; Bacigalupo A; Numico G; Crosetto N; Gasco M; Lo Nigro C; Vitiello R; Violante S; Garrone O
    Ann Oncol; 2011 Mar; 22(3):712-717. PubMed ID: 20810547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manageable early toxicity of cetuximab concurrent with radical radiotherapy for locally advanced head and neck cancer.
    Wieczorek A; Hamid A; O'Toole L
    Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):496. PubMed ID: 21482459
    [No Abstract]   [Full Text] [Related]  

  • 18. Cetuximab-induced pneumonitis in head and neck cancer patient.
    De Vos FY; Driessen CM; Jaspers HC; van Herpen CM; Simons B
    Oral Oncol; 2012 Jun; 48(6):e17-8. PubMed ID: 22342570
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review.
    Bonomo P; Loi M; Desideri I; Olmetto E; Delli Paoli C; Terziani F; Greto D; Mangoni M; Scoccianti S; Simontacchi G; Francolini G; Meattini I; Caini S; Livi L
    Crit Rev Oncol Hematol; 2017 Dec; 120():98-110. PubMed ID: 29198343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes.
    Giro C; Berger B; Bölke E; Ciernik IF; Duprez F; Locati L; Maillard S; Ozsahin M; Pfeffer R; Robertson AG; Langendijk JA; Budach W
    Radiother Oncol; 2009 Feb; 90(2):166-71. PubMed ID: 18977050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.